These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
232 related articles for article (PubMed ID: 26504851)
1. The Expansion of CD25 high IL-10 high FoxP3 high B Regulatory Cells Is in Association with SLE Disease Activity. Vadasz Z; Peri R; Eiza N; Slobodin G; Balbir-Gurman A; Toubi E J Immunol Res; 2015; 2015():254245. PubMed ID: 26504851 [TBL] [Abstract][Full Text] [Related]
2. Impaired suppressive capacity of activation-induced regulatory B cells in systemic lupus erythematosus. Gao N; Dresel J; Eckstein V; Gellert R; Störch H; Venigalla RK; Schwenger V; Max R; Blank N; Lorenz HM; Tretter T Arthritis Rheumatol; 2014 Oct; 66(10):2849-61. PubMed ID: 24942956 [TBL] [Abstract][Full Text] [Related]
3. Imbalance of different types of CD4(+) forkhead box protein 3 (FoxP3)(+) T cells in patients with new-onset systemic lupus erythematosus. Ma L; Zhao P; Jiang Z; Shan Y; Jiang Y Clin Exp Immunol; 2013 Dec; 174(3):345-55. PubMed ID: 23968502 [TBL] [Abstract][Full Text] [Related]
4. Human CD19(+)CD25(high) B regulatory cells suppress proliferation of CD4(+) T cells and enhance Foxp3 and CTLA-4 expression in T-regulatory cells. Kessel A; Haj T; Peri R; Snir A; Melamed D; Sabo E; Toubi E Autoimmun Rev; 2012 Jul; 11(9):670-7. PubMed ID: 22155204 [TBL] [Abstract][Full Text] [Related]
5. Dysfunctional CD4+,CD25+ regulatory T cells in untreated active systemic lupus erythematosus secondary to interferon-alpha-producing antigen-presenting cells. Yan B; Ye S; Chen G; Kuang M; Shen N; Chen S Arthritis Rheum; 2008 Mar; 58(3):801-12. PubMed ID: 18311820 [TBL] [Abstract][Full Text] [Related]
6. Clinical significance of increased CD4+CD25-Foxp3+ T cells in patients with new-onset systemic lupus erythematosus. Zhang B; Zhang X; Tang FL; Zhu LP; Liu Y; Lipsky PE Ann Rheum Dis; 2008 Jul; 67(7):1037-40. PubMed ID: 18199598 [TBL] [Abstract][Full Text] [Related]
7. Altered homeostasis of CD4(+) FoxP3(+) regulatory T-cell subpopulations in systemic lupus erythematosus. Suen JL; Li HT; Jong YJ; Chiang BL; Yen JH Immunology; 2009 Jun; 127(2):196-205. PubMed ID: 18800986 [TBL] [Abstract][Full Text] [Related]
8. The severity of systemic lupus erythematosus negatively correlates with the increasing number of CD4+CD25(high)FoxP3+ regulatory T cells during repeated plasmapheresis treatments of patients. Baráth S; Soltész P; Kiss E; Aleksza M; Zeher M; Szegedi G; Sipka S Autoimmunity; 2007 Nov; 40(7):521-8. PubMed ID: 17966042 [TBL] [Abstract][Full Text] [Related]
9. Reduced CD4+,CD25- T cell sensitivity to the suppressive function of CD4+,CD25high,CD127 -/low regulatory T cells in patients with active systemic lupus erythematosus. Venigalla RK; Tretter T; Krienke S; Max R; Eckstein V; Blank N; Fiehn C; Ho AD; Lorenz HM Arthritis Rheum; 2008 Jul; 58(7):2120-30. PubMed ID: 18576316 [TBL] [Abstract][Full Text] [Related]
10. Immunomodulation of human CD19 Hong M; Liao Y; Liang J; Chen X; Li S; Liu W; Gao C; Zhong Z; Kong D; Deng J; Zhang J; Pan G Hum Immunol; 2019 Oct; 80(10):863-870. PubMed ID: 31262519 [TBL] [Abstract][Full Text] [Related]
11. Inverse correlation between CD4+ regulatory T-cell population and autoantibody levels in paediatric patients with systemic lupus erythematosus. Lee JH; Wang LC; Lin YT; Yang YH; Lin DT; Chiang BL Immunology; 2006 Feb; 117(2):280-6. PubMed ID: 16423064 [TBL] [Abstract][Full Text] [Related]
13. [The proportion of CD19 Xie Z; Dai L; He H; Hong D; Wang Y; Xu W; Chen Z; Li B; Xie C Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2024 Feb; 40(2):148-157. PubMed ID: 38284256 [TBL] [Abstract][Full Text] [Related]
14. CD19(+)IL-10(+) regulatory B cells affect survival of tongue squamous cell carcinoma patients and induce resting CD4(+) T cells to CD4(+)Foxp3(+) regulatory T cells. Zhou X; Su YX; Lao XM; Liang YJ; Liao GQ Oral Oncol; 2016 Feb; 53():27-35. PubMed ID: 26631955 [TBL] [Abstract][Full Text] [Related]
15. Expression of CD19+CD24highCD38high B cells, IL‑10 and IL‑10R in peripheral blood from patients with systemic lupus erythematosus. Wang T; Li Z; Li X; Chen L; Zhao H; Jiang C; Song L Mol Med Rep; 2017 Nov; 16(5):6326-6333. PubMed ID: 28901380 [TBL] [Abstract][Full Text] [Related]
16. A regulatory role for CD72 expression on B cells in systemic lupus erythematosus. Vadasz Z; Haj T; Balbir A; Peri R; Rosner I; Slobodin G; Kessel A; Toubi E Semin Arthritis Rheum; 2014 Jun; 43(6):767-71. PubMed ID: 24461079 [TBL] [Abstract][Full Text] [Related]
18. Functional implications of regulatory B cells in human IgA nephropathy. Wang YY; Zhang L; Zhao PW; Ma L; Li C; Zou HB; Jiang YF Scand J Immunol; 2014 Jan; 79(1):51-60. PubMed ID: 24219615 [TBL] [Abstract][Full Text] [Related]
19. Regulatory B cells are enriched within the IgM memory and transitional subsets in healthy donors but are deficient in chronic GVHD. Khoder A; Sarvaria A; Alsuliman A; Chew C; Sekine T; Cooper N; Mielke S; de Lavallade H; Muftuoglu M; Fernandez Curbelo I; Liu E; Muraro PA; Alousi A; Stringaris K; Parmar S; Shah N; Shaim H; Yvon E; Molldrem J; Rouce R; Champlin R; McNiece I; Mauri C; Shpall EJ; Rezvani K Blood; 2014 Sep; 124(13):2034-45. PubMed ID: 25051962 [TBL] [Abstract][Full Text] [Related]
20. Adipose tissue-derived mesenchymal stem cells induce expansion of interleukin-10-producing regulatory B cells and ameliorate autoimmunity in a murine model of systemic lupus erythematosus. Park MJ; Kwok SK; Lee SH; Kim EK; Park SH; Cho ML Cell Transplant; 2015; 24(11):2367-77. PubMed ID: 25506685 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]